わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/06/14 | 日証協 | 271,509株 | +0.04% | 336,300株 | +83.27% | 413,834株 | +1.42% | 26,100株 | +18.64% |
2019/06/07 | 日証協 | 271,409株 | +11.5% | 183,500株 | +89.96% | 408,034株 | +3.37% | 22,000株 | -77.8% |
2019/05/31 | 日証協 | 243,409株 | +24.18% | 96,600株 | -52.3% | 394,734株 | +28.73% | 99,100株 | +114.04% |
2019/05/24 | 日証協 | 196,009株 | +13.43% | 202,500株 | +114.74% | 306,634株 | +5.69% | 46,300株 | +86.69% |
2019/05/17 | 日証協 | 172,809株 | +18.44% | 94,300株 | +47.57% | 290,134株 | +27.23% | 24,800株 | -65.36% |
2019/05/10 | 日証協 | 145,909株 | +0.97% | 63,900株 | -25.87% | 228,034株 | -0.22% | 71,600株 | +205.98% |
2019/04/26 | 日証協 | 144,509株 | +1.4% | 86,200株 | -4.01% | 228,534株 | +5.54% | 23,400株 | +0.43% |
2019/04/19 | 日証協 | 142,509株 | +1.35% | 89,800株 | +19.57% | 216,534株 | -0.51% | 23,300株 | +628.12% |
2019/04/12 | 日証協 | 140,609株 | +2.33% | 75,100株 | -52.68% | 217,634株 | -0.87% | 3,200株 | -87.04% |
2019/04/05 | 日証協 | 137,409株 | +4.89% | 158,700株 | -41.55% | 219,535株 | +22.5% | 24,700株 | -52.61% |
2019/03/29 | 日証協 | 131,009株 | +12.45% | 271,500株 | +1145.41% | 179,218株 | -12.93% | 52,117株 | +111.86% |
2019/03/22 | 日証協 | 116,509株 | +13.66% | 21,800株 | -87.1% | 205,833株 | +6.35% | 24,600株 | +32.97% |
2019/03/15 | 日証協 | 102,509株 | +7.1% | 169,000株 | +132.46% | 193,534株 | +4.54% | 18,500株 | -56.26% |
2019/03/08 | 日証協 | 95,709株 | +6.57% | 72,700株 | +45.69% | 185,134株 | +4.69% | 42,300株 | +164.38% |
2019/03/01 | 日証協 | 89,809株 | +0.66% | 49,900株 | -28.41% | 176,834株 | -14.59% | 16,000株 | +138.81% |
2019/02/22 | 日証協 | 89,221株 | -7.56% | 69,700株 | +52.85% | 207,034株 | -2.08% | 6,700株 | -52.48% |
2019/02/15 | 日証協 | 96,521株 | -13.76% | 45,600株 | -3% | 211,434株 | -8.48% | 14,100株 | -50% |
2019/02/08 | 日証協 | 111,921株 | +32.11% | 47,012株 | -61.66% | 231,034株 | +34.22% | 28,200株 | -66.71% |
2019/02/01 | 日証協 | 84,721株 | +17% | 122,612株 | +294.14% | 172,134株 | +9.69% | 84,700株 | +197.19% |
※株式分割は考慮していませんのでご注意ください。
Page Top